References
- Larsen, A K.; Skladanowski, A. Cellular resistance to topoisomerase-targeted drugs: from drug uptake to cell death. Biochim. Biophys. Acta 1998, 1400, 257–274. [PUBMED], [INFOTRIEVE]
- Loehrer, P J.; Einhorn, L H. Drugs five years later. Cisplatin. Ann. Intern. Med. 1984, 100, 704–713. [PUBMED], [INFOTRIEVE]
- Timmer-Bosscha, H.; Mulder, N H.; de Vries, E G. Modulation of cis-diamminedichloroplatinum(II) resistance: a review. Br. J. Cancer 1992, 66, 227–238. [PUBMED], [INFOTRIEVE]
- Andrews, P A.; Velury, S.; Mann, S C.; Howell, S B. cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res. 1988, 48, 68–73. [PUBMED], [INFOTRIEVE]
- Bungo, M.; Fujiwara, Y.; Kasahara, K.; Nakagawa, K.; Ohe, Y.; Sasaki, Y.; Irino, S.; Saijo, N. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair. Cancer Res. 1990, 50, 2549–2553. [PUBMED], [INFOTRIEVE]
- Meijer, C.; Mulder, N H.; Timmer-Bosscha, H.; Sluiter, W J.; Meersma, G J.; de Vries, E G. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds. Cancer Res. 1992, 52, 6885–6889. [PUBMED], [INFOTRIEVE]
- Lai, G M.; Ozols, R F.; Smyth, J F.; Young, R C.; Hamilton, T C. Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. Biochem. Pharmacol. 1988, 37, 4597–4600. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Masuda, H.; Ozols, R F.; Lai, G M.; Fojo, A.; Rothenberg, M.; Hamilton, T C. Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines. Cancer Res. 1988, 48, 5713–5716. [PUBMED], [INFOTRIEVE]
- Gottesman, M M.; Pastan, I. The multidrug transporter, a double-edged sword. J. Biol. Chem. 1988, 263, 12163–12166. [PUBMED], [INFOTRIEVE]
- Breuninger, L M.; Paul, S.; Gaughan, K.; Miki, T.; Chan, A.; Aaronson, S A.; Kruh, G D. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res. 1995, 55, 5342–5347. [PUBMED], [INFOTRIEVE]
- Cole, S P.; Sparks, K E.; Fraser, K.; Loe, D W.; Grant, C E.; Wilson, G M.; Deeley, R G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 1994, 54, 5902–5910. [PUBMED], [INFOTRIEVE]
- Koike, K.; Kawabe, T.; Tanaka, T.; Toh, S.; Uchiumi, T.; Wada, M.; Akiyama, S.; Ono, M.; Kuwano, M. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. Cancer Res. 1997, 57, 5475–5479. [PUBMED], [INFOTRIEVE]
- Larsen, A K.; Escarguil, A E.; Andrzej, S. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol. Ther. 2000, 85, 217–229. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Simon, S.; Roy, D.; Schindler, M. Intracellular pH and the control of multidrug resistance. Proc. Natl. Acad. Sci. 1994, 91, 1128–1132. [PUBMED], [INFOTRIEVE], [CSA]
- Castaing, M.; Loiseau, A.; Dani, M. Designing multidrug-resistance modulators circumventing the reverse pH gradient in tumours. J. Pharm. Pharmacol. 2001, 53, 1021–1028. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Huang, Z.; Huang, Y. Changes of the pHi and [Ca2 +]i are responsible for the anti-apoptosis character of A549/DDP cells. Prog. Biochem. Biophys. 2001, 28, 722–727.
- Liang, X.; Huang, Y. Physical state changes of membrane lipids in human lung adenocarcinoma A549 cells and their resistance to cisplatin. Int. J. Biochem. Cell Biol. 2002, 34, 1248–1255. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Perez-Sala, D.; Collado-Escobart, D.; Mollinedo, F. Intracellular alkalinization suppresses lovastatin-induced apoptosis in HL-60 cells through the inactivation of a pH-dependent endonuclease. J. Biol. Chem. 1995, 270, 6235–6242. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Thomas, J A.; Buchsbaum, R N.; Zimniak, A.; Racker, E. Intracellular pH measurements in ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 1979, 18, 2210–2218., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rajotte, D.; Haddad, P.; Hamman, A.; Cragoe, E J., Jr.; Hoang, T. Role of protein kinase C and the Na+/H+ antiporter in suppression of apoptosis by granulocyte macrophage colony-stimulating factor and intrtleukin-3. J. Biol. Chem. 1992, 267, 9980–9987. [PUBMED], [INFOTRIEVE]
- Melvin, S.; Sharon, G.; Hoff, E.; Simon, S M. Defective pH regulation of acidic compartment in human breast cancer cells (MCF-7) is normalized in adriamycin-rsistant cells (MCF-7 adr). Biochemistry 1996, 35, 28111–28117.
- Mayer, L D.; Bally, M B.; Cullis, P R. Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim. Biophys. Acta 1985, 816, 294–302. [PUBMED], [INFOTRIEVE]
- Mayer, L D.; Bally, M B.; Hope, M J.; Cullis, P R. Uptake of dibucaine into large unilamellar vesicles in response to a membrane potential. J. Biol. Chem. 1985, 260, 802–808. [PUBMED], [INFOTRIEVE]
- Rouser, G.; Fkeischer, S.; Yamamoto, A. Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 1970, 5, 494–496. [PUBMED], [INFOTRIEVE]
- Nielsen, D.; Skovsgaard, T. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines. Biochim. Biophys. Acta 1992, 1139, 169–183. [PUBMED], [INFOTRIEVE]
- Kruh, G D.; Zeng, H.; Rea, P A.; Liu, G.; Chen, Z S.; Lee, K.; Belinsky, M G. MRP subfamily transporters and resistance to anticancer agents. J. Bioenerg. Biomembranes 2001, 33, 493–501. [CSA], [CROSSREF]
- Akiyama, S.-i.; Chen, Z.-S.; Sumizawa, T.; Furukama, T. Resistance of cisplatin. Anti-Cancer Des. 1999, 14, 143–151. [CSA]
- Speelmans, G.; Sips, W H.H.M.; Grisel, R J.H.; Staffhorst, R W.H.M.; Fichtinger-Schepman, A M.J.; Reedijk, J.; Kruijff, B de. The interaction of the anti-cancer drug cisplatin with phospholipids is specific negatively charged phospholipids and takes place at low chloride ion concentration. Biochim. Biophys, Acta 1996, 1238, 60–66. [CSA]